Singaporean biotechs undertake a rigorous and systematic process when developing new therapeutic technologies. They identify an issue, hypothesise a range of possible solutions, progressively develop and test each of these solutions, and finally conclude on their efficacy in solving that issue. Unfortunately, many of these same biotechs fail to apply the same rigour when attempting […]

The post Poorly Executed Government Funding Disease: Know the Symptoms appeared first on Biotechin.Asia.